Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Multiple Endocrine Neoplasia × Leflunomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1

Conditions

Smoldering Multiple Myeloma 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neoplasms 1 Multiple Myeloma 1 Multiple Endocrine Neoplasia 1 Melanoma 1 Lung Neoplasms 1 Glioma 1 Colorectal Neoplasms 1 Central Nervous System Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

pertuzumab 1 gallium Ga 68 dotatate 1 fluorodopa F 18 1 Leflunomide 1 Erlotinib Hydrochloride 1 (18F)GTP1 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06540937 2024-08-07

Phase II Clinical Study of Leflunomide in the Treatment of MEN-1 Neuroendocrine Tumor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Recruiting

Multiple Endocrine Neoplasia, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡